PL2768313T3 - Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie - Google Patents

Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie

Info

Publication number
PL2768313T3
PL2768313T3 PL12772944T PL12772944T PL2768313T3 PL 2768313 T3 PL2768313 T3 PL 2768313T3 PL 12772944 T PL12772944 T PL 12772944T PL 12772944 T PL12772944 T PL 12772944T PL 2768313 T3 PL2768313 T3 PL 2768313T3
Authority
PL
Poland
Prior art keywords
magnesium
promotion
composition
retention
absorption
Prior art date
Application number
PL12772944T
Other languages
English (en)
Inventor
Clara Garcia-Rodenas
Matthias Hoppler
Cavin Elizabeth Offord
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2768313(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PL2768313T3 publication Critical patent/PL2768313T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12772944T 2011-10-18 2012-10-15 Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie PL2768313T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11185610 2011-10-18
PCT/EP2012/070404 WO2013057072A1 (en) 2011-10-18 2012-10-15 Composition for use in the promotion of magnesium absorption and/or magnesium retention
EP12772944.0A EP2768313B2 (en) 2011-10-18 2012-10-15 Composition for use in the promotion of magnesium absorption and/or magnesium retention

Publications (1)

Publication Number Publication Date
PL2768313T3 true PL2768313T3 (pl) 2016-02-29

Family

ID=47022680

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12772944T PL2768313T3 (pl) 2011-10-18 2012-10-15 Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie

Country Status (15)

Country Link
US (1) US9781947B2 (pl)
EP (1) EP2768313B2 (pl)
CN (1) CN103906435B (pl)
AU (1) AU2012324993B2 (pl)
BR (1) BR112014007829A2 (pl)
CL (1) CL2014000792A1 (pl)
ES (1) ES2546262T5 (pl)
MX (1) MX354727B (pl)
PH (1) PH12014500344A1 (pl)
PL (1) PL2768313T3 (pl)
PT (1) PT2768313E (pl)
RU (1) RU2604502C2 (pl)
TW (1) TW201316993A (pl)
WO (1) WO2013057072A1 (pl)
ZA (1) ZA201403592B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012532195A (ja) 2009-07-06 2012-12-13 チルドレンズ ホスピタル メディカル センター 乳オリゴ糖による炎症の阻害
US10857167B2 (en) 2015-04-28 2020-12-08 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
AU2017307952A1 (en) * 2016-08-04 2018-11-29 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally Bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
CN111479573B (zh) 2017-12-21 2024-05-24 雀巢产品有限公司 用于促进肠道肌肉生长和发育以及相关联的肠道能动性的组合物
EP3833195A1 (en) * 2018-08-08 2021-06-16 Mars Incorporated Pet food products comprising oligosaccharides and methods of use
CN114145458A (zh) * 2021-11-29 2022-03-08 内蒙古伊利实业集团股份有限公司 棕榈酸甘油酯在制备改善或促进人体镁吸收的组合物中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
JPH08283162A (ja) 1995-04-10 1996-10-29 Snow Brand Milk Prod Co Ltd ミネラル吸収促進剤
US5939394A (en) * 1996-01-18 1999-08-17 Fleming & Company Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
GB0028238D0 (en) 2000-11-20 2001-01-03 Cerestar Holding Bv Indigestible oligosaccharides and magnesium absorption in humans
US7435431B2 (en) * 2004-07-28 2008-10-14 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
WO2007090894A1 (en) * 2006-02-10 2007-08-16 Nestec S.A. Oligosaccharide mixture
US9005682B2 (en) 2006-03-07 2015-04-14 Nestec S.A. Synbiotic mixture
ES2634613T3 (es) * 2006-08-30 2017-09-28 Prolacta Bioscience, Inc. Métodos de obtención de leche estéril y composiciones de la misma
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2265135B1 (en) * 2008-03-14 2017-12-20 Nestec S.A. Synbiotic mixture
WO2010068086A1 (en) * 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
CN107087793A (zh) * 2009-07-15 2017-08-25 N·V·努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
EP2509429A1 (en) * 2009-12-08 2012-10-17 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
BR112013031086A2 (pt) 2011-06-08 2016-11-29 Nestec Sa composições nutricionais tendo componentes de membrana de glóbulo de gordura de leite exógenos

Also Published As

Publication number Publication date
US9781947B2 (en) 2017-10-10
TW201316993A (zh) 2013-05-01
EP2768313B1 (en) 2015-08-12
BR112014007829A2 (pt) 2017-04-18
MX354727B (es) 2018-03-16
CL2014000792A1 (es) 2014-08-22
CN103906435B (zh) 2016-11-23
AU2012324993B2 (en) 2015-11-26
MX2014004709A (es) 2015-02-05
AU2012324993A2 (en) 2014-06-12
PH12014500344A1 (en) 2014-04-14
EP2768313A1 (en) 2014-08-27
RU2604502C2 (ru) 2016-12-10
AU2012324993A1 (en) 2014-02-27
ES2546262T5 (es) 2019-04-12
US20140255543A1 (en) 2014-09-11
WO2013057072A1 (en) 2013-04-25
EP2768313B2 (en) 2019-01-02
ES2546262T3 (es) 2015-09-22
PT2768313E (pt) 2015-10-14
RU2014119845A (ru) 2015-11-27
CN103906435A (zh) 2014-07-02
ZA201403592B (en) 2015-12-23

Similar Documents

Publication Publication Date Title
GB2478595B (en) Phytocannabinoids in the treatment of glioma
GB201120993D0 (en) Novel compounds and their use in therapy
IL229431A0 (en) Preparations against cgrp and their use
PL2917231T3 (pl) Lipopeptydy do stosowania w leczeniu chorób wątroby i chorób sercowo-naczyniowych
ZA201307236B (en) Special fluid composition and use thereof
EP2744356A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING INCOUNTERANCE IN ANIMALS
IL236637A0 (en) Difluorolactam compounds as selective ep4 receptor agonists for use in the treatment of ep4-mediated conditions and diseases
ZA201403592B (en) Composition for use in the promotion of magnesium absorption and/or magnesium retention
GB201106357D0 (en) Composition and uses thereof
ZA201208454B (en) Use of diatomaceous earth in the pharmaceutocal industry
IL233875A0 (en) A preparation and its use for the treatment of anal fissures
EP2968374A4 (en) METHODS AND COMPOSITIONS FOR IMPROVING OXYGEN RATE IN FABRICS
GB201120834D0 (en) Improvements in or relating to stairlifts
PL2925828T3 (pl) Kompozycja do usuwania zanieczyszczeń i jej zastosowanie
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
GB201004004D0 (en) Improvements in and relating to the consideration of evidence
GB201216396D0 (en) A composition for reducing the consumption of food and the absorption of its carbohydrate constituents
LT2749168T (lt) Gofruota kompozicija ir jos naudojimas
SI2699545T1 (sl) Novi amino-pirolinski derivati in uporaba le-teh pri preprečevanju in/ali zdravljenju metaboličnega sindroma
GB201019999D0 (en) Improvements in or relating to the retention of bearings
SG11201400742PA (en) Composition to be applied to the skin, and use thereof
LT2863932T (lt) Kompozicija, skirta naudoti limfedemos gydymui
GB201110302D0 (en) Improvements in and relating to the consideration of evidence
PL2688418T3 (pl) Bogata w stygmasterol kompozycja fitosterolowa i jej zastosowania
GB201215352D0 (en) Improvements in and relating to the anaalysis of sample